Summary

Report Overview
The Global Portable Hemodialysis Market reached US$ 20.2 billion in 2023 and is expected to reach US$ 35.38 billion by 2031, growing at a CAGR of 7.4% during the forecast period 2024-2031.
Hemodialysis is a treatment that replaces the work of one’s kidneys to clear wastes and extra fluid from the blood. This is done using a special filter called a dialyzer or artificial kidney. The blood travels through plastic tubing to the dialyzer, where it is cleaned and then returned to the patient. At the beginning of each treatment, two needles are placed into the access. These needles are connected to the plastic tubing that carries the blood to the dialyzer. Only a small amount of blood is out from the body at any one time. The dialysis machine pumps the blood through the dialysis system and controls the treatment time, temperature, fluid removal, and pressure.
A portable hemodialysis device is a medical device, which can be moved from one location to another location easily so that it is beneficial for the patient and the device can be carried to the patient’s location. Nowadays, kidney diseases and disorders are increasing at an alarming rate which is increasing the need for portable hemodialysis products.
Market Dynamics: Drivers
Increasing prevalence of chronic kidney disorders
The demand for the global portable hemodialysis market is driven by multiple factors. The rising prevalence of chronic kidney disorders propels the market growth.
Furthermore, the demand for treatment will be fueled by the increase in technological advancements. For instance, according to nih.gov, chronic kidney disease is a progressive condition that affects >10% of the general population worldwide, amounting to >800 million individuals. Chronic kidney disease is more prevalent in older individuals, women, racial minorities, and people experiencing diabetes mellitus and hypertension. Chronic kidney disease represents an especially large burden in low- and middle-income countries, which are least equipped to deal with its consequences.
For instance, according to the National Kidney Foundation, over 2 million people worldwide currently receive treatment with dialysis or a kidney transplant to stay alive, yet this number may only represent 10% of people who actually need treatment to live. It is estimated that the number of cases of kidney failure will increase disproportionately in developing countries, such as China and India, where the number of elderly people is increasing. Of the 2 million people who receive treatment for kidney failure, the majority are treated in only five countries – the United States, Japan, Germany, Brazil, and Italy. These five countries represent only 12% of the world's population. Only 20% are treated in about 100 developing countries that make up over 50% of the world population.
Restraints
Factors such as complications linked with the procedure and lack of awareness among people are expected to hamper the market. According to statistics from the National Kidney Foundation in the United States, 10 percent of the world’s population is affected by chronic kidney disease and it is the 12th most common cause of death. Millions die annually due to a lack of access to affordable treatment.
Market Segment Analysis
The global portable hemodialysis market is segmented based on product, pumping system, end-user, and region.
The segment portable devices accounted for approximately 49.7% of the global portable hemodialysis market share
The portable devices segment is expected to hold the largest market share over the forecast period. In this segment, the technological advancements, and rising funds for private manufacturers for device development would drive this market.
For instance, in March 2024, Bussum, the Netherlands-based Nextkidney, a medtech company, announced that it has developed the world’s first portable hemodialysis device, Neokidney. According to the Dutch company, Neokidney is in the final development phase and is expected to launch in the Netherlands by 2024.
Moreover, in August 2024, Synopex, a medical device manufacturer, obtained marketing authorization from the Ministry of Food and Drug Safety (MFDS) for the nation's first independently developed continuous renal replacement therapy (CRRT) device for critical care patients.
Market Geographical Analysis
North America accounted for approximately 42.3% of the global portable hemodialysis market share
North America region is expected to hold the largest market share over the forecast period. The rising incidence of chronic kidney diseases, technological advancements, and increase in fund allotment in this region, help to propel the market.
For instance, according to American Kidney Fund, An estimated 35.5 million Americans have kidney disease. About 808,000 Americans are living with kidney failure. More than 557,000 Americans are on dialysis. Kidney disease is growing at an alarming rate. It currently affects more than 1 in 7 (or 14%) of American adults, with people of color at greater risk for kidney failure. There were about 135,000 Americans newly diagnosed with kidney failure in 2021. 9 out of 10 people with kidney disease are unaware they have it, and 1 in 3 of those with severely reduced kidney function (but not yet on dialysis) are unaware they have kidney disease.
Moreover, in September 2023, AWAK Technologies obtained more than $20m in Series B funding for the US-based pivotal trial of its wearable dialysis device. AWAK PD, the ultra-portable peritoneal dialysis (PD) system allows kidney disease patients to undergo dialysis at home and anywhere on the go. The company will use the proceeds for various crucial initiatives to conclude its ongoing human pre-pivotal clinical study with Singapore General Hospital. The funding will also help the company improve the ultraportable PD device for the final pivotal trial in the US, anticipated to begin in 2025.
Market Segmentation
By Product
Portable Devices
Consumables
Blood Lines
Dialyzer and Dialysate
Software and Services
Others
By Pumping System
Single Pump
Double Pump
By End-User
Hospitals
Specialty Clinics
Dialysis Centers
Homecare
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
U.K.
France
Spain
Italy
Rest of Europe
South America
Brazil
Argentina
Rest of South America
Asia-Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
Middle East and Africa
Market Competitive Landscape
The major global players in the global portable hemodialysis market include NxStage Medical Inc., Quanta Dialysis Technologies, Cantel Medical Group of Companies, AWAK Technologies, Medtronic, SB Kawasumi Laboratories, Texas Instruments Incorporated., Baxter, Diality, and Teleflex Incorporated. among others.
Key Developments
In April 2023, AWAK Technologies, a Singapore-based medical technology company, recently received FDA Breakthrough Device designation for their wearable and portable dialysis device. The AWAK Peritoneal Dialysis device, or AWAK PD, uses AWAK’s patented sorbent technology and offers a convenient means of dialysis for renal disease patients.
In June 2022, NextKidney recently announced that it had acquired Dialyss Pte. Ltd. to boost the development of its portable Neokidney hemodialysis device. NextKidney officials boast that the Neokidney will be a small, user-friendly, home hemodialysis device, using only 4 liters of fluid per session. In addition, they say that it can run entirely independent of water supply and drain, enabling people to use it anytime and anywhere.
Why Purchase the Report?
To visualize the global portable hemodialysis market segmentation based on product, pumping system, end-user, and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development
Excel data sheet with numerous data points of global portable hemodialysis market level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping is available in Excel consisting of key products of all the major players.
The global portable hemodialysis market report would provide approximately 51 tables, 54 figures, and 181 Pages.
Target Audience 2024
Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

ページTOPに戻る

Table of Contents

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Pumping System
3.2. Snippet by Product
3.3. Snippet by End-User
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing Prevalence of Chronic Diseases
4.1.1.2. Technological Advancements
4.1.2. Restraints
4.1.2.1. Complications Linked With Procedure
4.1.2.2. Lack of Awareness
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs
5.6. PESTEL Analysis
5.7. Patent Analysis
5.8. SWOT Analysis
6. By Product Type
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
6.1.2. Market Attractiveness Index, By Product Type
6.2. Portable Devices*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Consumables
6.4. Software and Services
6.5. Others
7. By Pumping System
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pumping System
7.1.2. Market Attractiveness Index, By Pumping System
7.2. Single Pump*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Double Pump
8. By End-User
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.1.2. Market Attractiveness Index, By End-User
8.2. Hospitals*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Specialty Clinics
8.4. Dialysis Centers
8.5. Homecare
8.6. Others
9. By Region
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pumping System
9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.2.6.1. The U.S.
9.2.6.2. Canada
9.2.6.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pumping System
9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.3.6.1. Germany
9.3.6.2. UK
9.3.6.3. France
9.3.6.4. Italy
9.3.6.5. Spain
9.3.6.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pumping System
9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.4.6.1. Brazil
9.4.6.2. Argentina
9.4.6.3. Rest of South America
9.5. Asia-Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pumping System
9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.5.6.1. China
9.5.6.2. India
9.5.6.3. Japan
9.5.6.4. South Korea
9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pumping System
9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10. Competitive Landscape
10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis
11. Company Profiles
11.1. NxStage Medical Inc. *
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Financial Overview
11.1.4. Key Developments
11.2. Quanta Dialysis Technologies
11.3. Cantel Medical Group of Companies
11.4. AWAK Technologies
11.5. Medtronic
11.6. SB Kawasumi Laboratories
11.7. Texas Instruments Incorporated. Incorporated.
11.8. Baxter
11.9. Diality
11.10. Teleflex Incorporated. (*LIST NOT EXHAUSTIVE)
12. Appendix
12.1. About Us and Services
12.2. Contact Us